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I. Introduction 
The elongation factor EF-Tu has two important 
functions in the bacterial cell; it acts as a translational 
factor in protein synthesis [ 1,2] and as a subunit of 
phage RNA replicase [3]. Its intracellular abundance 
is surprisingly high [4-71. Escherkhia coli harbours 
two genes coding for EF-Tu: tufA, located at 73 mm 
on the E. coli linkage map [8], lies in the so-called str 
region [9] as the distal-most gene of a 4-gene operon 
[lo]; tuj73 lies in the rif region near 88 min [9] and is 
co-transcribed with 4 upstream tRNA genes [11,131. 
The nucleotide sequences of tufA and tu~?B have been 
determined [14,15]. 
in [20] was used with some modifications (in prepa- 
ration). The specificity of the antisera was checked 
with immunoelectrophoresis. 
2.2. Methods 
hrfA and fujB are remarkably similar in ucleotide 
sequence and differences have been found at 13 posi- 
tions only. Their corresponding gene products, 
EF-TuA and EF-TUB, are almost identical and differ 
only in the C-terminal amino acid [ 16,171. The struc- 
ture and the arrangement of the two tuf genes raise a 
number of genetic and regulatory problems. Here, we 
address the question of the regulation of their expres- 
sion. We show that inactivation of tufB does not alter 
the expression of tufA . One single site mutation in 
tufA, however, has a drastic effect on the expression 
of tujB. This indicates that the EF-Tu protein exerts 
a regulatory function in tu_fB expression. 
Cultures were grown in rich or in minimal medium. 
In order to vary the growth rate minimal medium was 
supplemented with different carbon sources (cf. 
table 1). For the preparation of ‘crude extracts’ cells 
were rapidly cooled in ice, harvested by centrifugation 
and broken by ultrasonication. The ‘crude extracts’ 
thus obtained were analyzed as such for EF-Tu and 
EF-Ts (see below). For preparation of ribosome-free 
supematants he ‘crude extract’ was clarified by cen- 
trifugation at 30 000 X g. The supematant (S-30) was 
centrifuged at 100 000 X g, yielding a ribosome-free 
supematant (S-100). The ribosomal pellet was washed 
once in 1 M N&Cl, resuspended and the AZM) of the 
suspension was measured to determine the cellular 
content of ribosomes [21]. 
Intracellular amounts of EF-Tu and EF-Ts were 
determined in ‘crude extracts’ by rocket immuno- 
electrophoresis based on the method in [22]; standard 
deviations were <5% (cf. fig.1). 
2. Materials and methods 
2.1. Materials 
Since our measurements yielded higher steady 
state EF-Tu and EF-Ts levels than reported by others 
[4-6,401 control experiments were performed (to be 
published elsewhere); they revealed that the immuno- 
logical assay employed here, which makes fractiona- 
tion of the ruptured cells superfluous, avoids losses of 
EF-Tu and other sources of errors and thus i  prefer- 
able to other methods. 
EF-Tu . GDP and EF-Ts were isolated as homoge- 
neous proteins by affinity chromatography according 
to [ 181. Antibodies against EF-Tu were prepared as in 
[ 191. For the preparation of anti-EF-Ts the procedure 
EF-TuA and EF-TUB species differing in isoelectric 
point were assayed separately by submitting S-l 00 
preparations toisoelectric focusing on 6 mm cylindrical 
gels as in [23]. The gels were then rapidly frozen and 
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Table 1 
Growth rates of different strains of Escherichia coli K12 altered in tufA and/or 
tufB in different media 
Strain EF-TuC Generation times (doublings/h) 
symbols 
LC cas.a.a. Glucose Rhamnose Acetate 
LBE 1001 ASBS n.d.a 2.30 0.99 0.68 0.24 
LBE 2020 ASBO 2.25 1.50 0.89 0.52 0.30 
LBE 2021 ARBO 1.95 1.16 0.63 0.43 
b 
PM 505 AS n.d.a 1.85 0.92 0.65 Zb 
PM 455 AR 2.11 1.37 0.88 0.48 
b 
PM 816 ARBS 1.98 1.39 0.89 0.63 On:& 
a Not done; b no growth possible; c see table 2 
Cells were grown in different media to obtain various generation times. The rich 
medium (LC) contains per liter: 10 g bactotrypton, 5 g yeast extract, 8 g NaCl, 
lo-” M Tris, 10M2 M MgCl,, 20 mg thymine, 0.2% glucose. The minimal medium 
(VB [41]) contains per liter: 200 mg MgSO,. 7 H,O, 2 g citric acid, 10 g K,HPO,, 
3.5 g Na(NH,)HPO, a4 H,O, and a mixture of MnSO, - H,O (50 mg) and 
FeSO, . 7 H,O (SO mg), which was sterilized separately. In order to vary the 
growth rate VB medium was supplemented with the carbon sources indicated in 
table 1 as cas.a.a. (casamino acids 0.5% + glucose 0.4%), glucose (glucose 0.4%), 
rhamnose (rhamnose 0.4%) and acetate (sodium acetate 1%) 
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Fig.1. The standard curves for quantitative determinations of 
EF-Tu (left) and EF-Ts (right) by means of rocket immuno- 
electrophoresis. The curves were obtained by adding increasing 
amounts of EF-Tu * GDP (EF-Ts) to the wells (diam. 4.5 mm) 
of the gel. Pure EF-Tu . GDP was dissolved in a buffer con- 
taining Tris-HCl, 10 mM (pH 7.8), 10 mM magnesium ace- 
tate, 10 PM GDP, 0.1 mM phenylmethylsulphonyl f uoride, 
1 mM dithioerythritol and 2 mg bovine serum albumin/ml. 
Pure EF-Ts was dissolved in the same buffer with a 4-fold 
excess of EF-TU . GDP. The conditions for the formation of 
the immunoprecipitates (rockets) will be published elsewhere. 
The stained gels were photographed and the enlarged prints 
were used to cut out the areas under the rockets. The weights 
of the cuttings were plotted in arbitrary units (u) as a func- 
tion of the amount of factor proteins. 
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cut into 1 mm slices which were subjected to rocket 
immunoelectrophoresis. Reference gels containing 
pure EF-TU and S-100 extracts were run, fixed and 
stained for the exact location of EF-TuA and EF-TUB 
(fig.2). Cellular proteins were assayed as in [24]. The 
results were checked by amino acid analysis. 
3. Results 
3.1. Ou dine of the experimental approach 
Regulation of tufA and tujB expression was studied 
by determining the intracellular contents of EF-TuA 
and EF-TUB in various mutant strains of E. coli under 
varying steady state growth conditions. 
The mutant strains listed in table 2 were con- 
structed for this purpose. They are all derived from 
the kirromycin-resistant mutant LBE 2012 which 
harbours a tufA coding for a kirromycin-resistant 
EF-TuA designated EF-TuAR and a mutated tu@ 
coding for an EF-TUB, sensitive to the antibiotic. The 
mutation in tujIi3 of LBE 2012 is recessive with respect 
to that in tufA and the corresponding EF-TUB (desig- 
nated EF-TUB,) does not immobilize the ribosome 
on the messenger upon binding of kirromycin [25-271 
as does wild-type EF-Tu [28]. 
Each strain is designated by its serial number sup- 
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Fig.2. Isoelectric focusing of pure EF-Tu from strain LBE 
2021, ARBG (gel A) and of an S-100 fraction from the same 
strain (gel B). Purified EF-Tu (20 Ng) or S-100 protein (100 pg) 
were loaded on the gel and run as in [ 231. Positions of 
EF-TuAR and EF-TuBG are indicated. EF-Tu from strain 
LBE 2021, ARBG was purified by means of affinity chroma- 
tography [ 181. S-100 fraction was obtained from strain LBE 
2021, ARBG cultured in rich medium (LC). 
Table 2 
Escherichio coli K12 strains used during this study 
Strain EF-Tu” Genotype Phenotypeb 
symbols 
LBE 1001 ASBS Wild-type 
LBE 2020 ASBO tufB, rpoB Rif’ 
LBE 2021 ARBG tufA, tufB, rpoB Kir’, Rif’ 
PM505 AS tufB::(Mu), rpoB Rifr 
PM 455 AR tufA, tufB::(Mu), rpoB Kir’, Rif’ 
PM 816 ARBS mfA> fus Fus’ 
LBE 2012 ARBG xyl, mfA, mfB KirT 
a The designations AS, AR, BS and BG refer, respectively, to 
a wild-type tufA product, a kirromycin-resistant tufA prod- 
uct, a wild-type tufB product and an altered tufB product, 
the properties of which have been described in [ 25 -271 
b Kir’, kirromycin resistance; Rif’, rifampicin resistance; 
Fus’, fusidic acid resistance 
Strains LBE 2012 and 1001 have been described in [ 391. 
LBE 2020 was obtained by Pl transduction using LBE 2014 
[ 391 as donor and LBE 1001 as recipient. Selection was for 
rifampicin resistance and screening for EF-TuBG according 
to [25]. LBE 2021 was obtained by Pl transduction using 
LBE 2014 as donor and LBE 2020 as recipient. Selection was 
for kirromycin resistance. Strain PM 505 was derived from 
strain LBE 2045 [39] by Pl transduction using LBE 2045 as 
donor and LBE 1001 as recipient. Selection was for rifampicin 
resistance and screening for Mu-production. Strain PM 455 
was constructed by Pl transduction using PM 505 as recipi- 
ent and LBE 2012 as donor. Selection was for kirromycin 
resistance. PM 816 was obtained by PI transduction using 
LBE 1001 as recipient and LBE 2015 [39] as donor. Selec- 
tion was for fusidic acid resistance. To ensure the presence of 
the mutated fufA (AR) gene in strain PM 816, a second Pl 
transduction was performed with LBE 2012 as donor and 
PM 816 as recipient. Selection was for kirromycin resistance 
plemented with the corresponding EF-Tu symbols 
(tables 1,2). Since it is essential to work with E. coli 
strains which are isogenic except for the tifgenes 
under study we transduced tuf genes of LBE 2012, 
ARBO and LBE 2045, AR into the wild-type strain 
LBE 1001, ASBS . 
To determine the intracellular amounts of EF-TU 
(and EF-Ts) rocket immunoelectrophoresis of total 
crude bacterial extracts was used (to be published 
elsewhere). For the determination of the relative 
amounts of EF-TuA and EF-TUB advantage was taken 
of the fact that EF-TuBo differs in isoelectric point 
from wild-type EF-TU and EF-TuAB by 0.1 pH unit 
[25]. This enabled separation of the two EF-TU spe- 
cies present in ribosome-free supernatants by isoelec- 
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Fig.3. CeBular amounts (nmol) of EF-Tu in various strains of E. coli altered in tufA and/or fufB at different growth rates. The 
content of EF-Tu was determined in crude bacterial extracts by means of rocket immunoelectrophoresis (section 2). The EF;lh 
concentration is plotted against growth rate. The growth rates were varied by culturing the cells in media with different carbon 
sources (table 1). The EF-Tu symbols refer to the strains mentioned in table 2. 
Fig.4. The cellular amounts (nmol) of EF-TuAS and EF-TuBC in crude extracts of strain LBE 2020, ASBC cultured at different 
growth rates. The total cellular amount (nmol) of EF-Tu from strain PM 505, AS is also indicated. Isoelectric focusing and rocket 
immuno-electrophoresis a  in section 2 were used for the quantitative determination of each protein. For growth conditions com- 
pare legend to fig.3. 
Fig.5. The cellular amounts (mnol) of EF-TuAR and EF-TuBC in crude extracts of strain LBE 2021, ARBC cultured at different 
growth rates. The total cellular amount (nmol) of EF-Tu from strain PM 455, AR is also presented. For further experimental 
details see section 2 and fig.3,4. 
tric focusing and analysis of the separated species by 
rocket immunoelectrophoresis. The ratios thus 
obtained for ribosome-free supernatants and the total 
EF-Tu contents of crude bacterial extracts were used 
to calculate the intracellular amounts of EF-TuA and 
EF-TUB. 
3.2. Inactivation of tufB does not affect the 
expression of tufA 
The cellular EF-TU content (nmol EF-Tu/mg crude 
extract protein) varies linearly with the growth rate 
under steady state growth conditions for most of the 
strains tudied (fig.3), in agreement with [4,6,7,12,29]. 
A slight deviation from this behaviour was found for 
strains LBE 2021, ARBO and PM 816, ARBS. The 
EF-Tu contents of cells with a wild type tufA gene 
and a non-functional tujB (PM 505, As) is reduced 
by 43% as compared to wild-type cells (LBE 1001, 
AsBs) and strain LBE 2020, AsBo . This reduction is 
the same for all growth rates studied. Interestingly 
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the intracellular content of the single tufA gene prod- 
uct: EF-TuAs from strain PM 505, As is identical to 
that of cells from LBE 2020, A,Bo at comparable 
growth rates in (fig.4). 
Apparently the cells from PM 505, As do not com- 
pensate for the loss of the tujB gene by an increased 
expression of the tufA gene. A similar conclusion 
emerges when the EF-TuAR content of cells from 
PM 455, AR is compared to that of LBE 2021, ARBo 
cells (fig.5); exactly the same levels of EF-TuAR are 
found in both strains at comparable growth rates. 
These experiments herefore demonstrate hat 
inactivation of &jl3 does not affect the expression of 
tufA at growth rates varying from -0.4-2.0 dou- 
blings/h. A single site mutation in tuflp as present in 
LBE 2020, AsBo does not influence the expression 
of tufA either. This is demonstrated by the data in 
fig.3 showing that the total amounts of EF-Tu in cells 
from LBE 1001, ASBS are identical to those of cells 
from LBE 2020, A,B,. 
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3.3. A specific single site mutation of tufA disturbs 
the coordinate expression of tufA and tufB 
Cells from LBE 2020, A,B, display a coordinate 
expression of tufA and tu_f23, confirming [31]. This 
can be deduced from tig.4, which illustrates that 
EF-TuA, and EF-TUB, occur in these cells in a con- 
stant molar ratio f 1.3 at all growth rates studied. 
Since the B, mutation of lz@3 has no apparent effect 
on the expression of tufA (see above) and the total 
EF-Tu level of LBE 2020, AsBo is identical to that 
of wild-type cells from LBE 1001, AsBS this coordi- 
nate expression of the two tuf genes most likely also 
occurs in the latter cells. 
However, the.specific single site mutation of tufA, 
rendering the EF-TuA product resistant to the anti- 
biotic kirromycin, disturbs this coordinate xpression 
completely as is evident from the data presented in 
fig.5. Fig.5 reveals that the EF-TuAR/EF-TUBS ratio 
of strain LBE 2021, A,Bo decreases upon lowering 
of the growth rate, whereas the ratio of EF-TuAs/ 
EF-TUB, of strain LBE 2020, AsBO remains constant 
under these conditions. This difference can be ascribed 
almost exclusively to an enhanced expression of 2ujI3 
which becomes more pronounced at lower growth 
rates. This enhanced expression of tujB also becomes 
apparent in the total EF-Tu levels of LBE 2021, 
ABB, and PM 816, ARBS as presented in fig.3. They 
are significantly increased as compared to those of 
LBE 2020, AsBo and LBE 1001, ASBS, both harbour- 
ing wild-type tufA . 
It may be noted that the EF-TUAR contents of 
LBE 2021, ARBO and of PM 455, AR (fig.5) @holy 
but significantly exceed those of EF-TuAs of LBE 
2020, ASBO and PM 505, A, (fig.4) at growth rates 
>l .O doubling/h. This also contributes to the elevated 
EF-TU levels of LBE 2021, ARBo and PM 816, ARBS 
(fig.3) but this effect of the mutation of tufA is rela- 
tively small and it remains to be seen whether this is a 
direct or an indirect effect on the expression of tufA. 
4. Discussion 
In wild-type cells the expression of tufA and ruf23 
is regulated coordinately (fig.4, [31]). Remarkably 
the expression of tufA remains unchanged upon com- 
plete inactivation of Fuji by the insertion of the bac- 
teriophage Mu. Apparently the expression of tufA is 
independent of that of lufi. On the contrary, in [30] 
it was reported that cells lacking a functional t&B, 
due to Mu insertion, compensate for the loss of the 
latter gene by increasing the expression of tufA. A 
strain (KB 31) originally constructed in our laboratory 
and comparable to PM 505, As (table 2) was used 
[30]. The conclusion in [30] is unwarranted, since it 
was based on comparisons of tuf mRNA levels of 
non-isogenic strains. 
A most significant finding of this investigation is
that the coordinate xpression of tufA and tu.03 
breaks down completely by a specific single site muta- 
tion of tufA , rendering EF-TuA resistant to kirromy- 
tin. We cannot exclude the possibility that the effect 
of the tufA mutation on the expression of tufB is 
indirect. This seems less likely, however, since the 
enhancement of tujB expression, which becomes 
more pronounced at lower growth rates, is specific in 
the sense that the expression of tsf (coding for EF-Ts) 
and that of the ribosomal genes is not affected by the 
tufA mutation under all environmental conditions (in 
preparation). Therefore, our data are more readily 
explained by a direct involvement of a product of the 
mutated tufA gene on the expression of t~_tB. 
The tufA mutation is due to a G + A transition 
resulting in a replacement of alanine by threonine at 
position 375 of the EF-TuA chian [32]. This replace- 
ment could be directly responsible for the enhanced 
expression of tuj??, and would imply that the EF-Tu 
protein itself exerts an autogenous control function 
in trQ.B expression. One can only speculate about the 
level at which EF-Tu might exert this regulatory func- 
tion. In [33] it was reported that the complex 
EF-Tu e EF-Ts stimulates transcription of rRNA genes 
and a control function of EF-Tu in regulating tu@ 
transcription may be considered. However, in [34,35] 
no specific effect of EF-Tu on rRNA synthesis or on 
RNA polymerase activity was detected. An autoge- 
nous control of the expression of ribosomal protein 
genes has been demonstrated atthe level of transla- 
tion (review [36]). 
Certain key ribosomal proteins (r-proteins) act as 
negative feedback regulators, inhibiting the translation 
of mRNA coding for themselves and for certain other 
r-proteins in the same transcription unit. In the case 
of S4, S7 and S8, structural homologies have been 
reported to exist between the binding sites on 16 S 
rRNA and the target sites on the mRNAs coding for 
the respective r-proteins [37,38]. The possibility that 
EF-Tu controls the expression of t~jB by affecting 
the translation of tujZ3 mRNA therefore deserves seri- 
ous consideration. 
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The fact that h@I is cotranscribed with 4 upstream 
tRNA genes may provide the primary transcript with 
one or more target sites for EF-TU binding which are 
structurally homologous to aminoacyl-tRNA, the 
binding partner of EF-Tu - GTP during the elongation 
cycle. Our recent experiments (to be published else- 
where), using plasmids harbouring tufA or nrfl3, sup- 
port this model. 
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